TD Cowen raised the firm’s price target on Genpact (G) to $45 from $40 and keeps a Hold rating on the shares. The firm said its path of F2024 outperformance continued with revenue/EPS beating while a healthy close to the year is targeted too with its 4Q revenue/EPS outlook.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.